SCIVANTA MEDICAL CORP Research and Development Expense
SCIVANTA MEDICAL CORP reported Research and Development Expense of $3.12 thousand for the 12-month period ending 2013-10-31, per its 10-K filed 2015-02-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2015-02-13
- SCIVANTA MEDICAL CORP research and development expense for the quarter ending 2013-10-31 was $0.00, a 100.00% decline year-over-year.
- SCIVANTA MEDICAL CORP research and development expense for the quarter ending 2013-07-31 was $3.12K, a 43.77% decline year-over-year.
- SCIVANTA MEDICAL CORP research and development expense for the quarter ending 2012-10-31 was $7.29K, a 3070.00% increase year-over-year.
- SCIVANTA MEDICAL CORP research and development expense for the quarter ending 2012-07-31 was $5.54K, a 20.06% decline year-over-year.
- SCIVANTA MEDICAL CORP research and development expense for fiscal 2013 was $3.12K, a 85.66% decline from fiscal 2012.
- SCIVANTA MEDICAL CORP research and development expense for fiscal 2012 was $21.72K, a 47.67% decline from fiscal 2011.
- SCIVANTA MEDICAL CORP research and development expense for fiscal 2011 was $41.51K, a 157.64% increase from fiscal 2010.
- SCIVANTA MEDICAL CORP research and development expense for fiscal 2010 was $16.11K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2013-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $3.12K derived: sum of 2 quarters · filed 2015-02-13 | $3.12K 10-K · filed 2015-02-13 | |
| 2013-07-31 | $3.12K 10-Q · filed 2014-09-12 | $3.12K 10-Q · filed 2014-09-12 | ||
| 2012-10-31 | $7.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-21 | $12.83K derived: sum of 2 quarters · filed 2014-01-21 | $12.83K derived: sum of 3 quarters · filed 2014-01-21 | $21.72K 10-K · filed 2014-01-21 |
| 2012-07-31 | $5.54K 10-Q · filed 2013-09-16 | $5.54K derived: sum of 2 quarters · filed 2013-09-16 | $14.43K 10-Q · filed 2013-09-16 | $14.66K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | $0.00 10-Q · filed 2012-06-14 | $8.89K 10-Q · filed 2013-06-14 | $9.12K derived: sum of 3 quarters · filed 2013-03-18 | $16.05K derived: sum of 4 quarters · filed 2013-03-18 |
| 2012-01-31 | $8.89K 10-Q · filed 2013-03-18 | $9.12K derived: sum of 2 quarters · filed 2013-03-18 | $16.05K derived: sum of 3 quarters · filed 2013-03-18 | $42.70K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-10-31 | $230.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $7.16K derived: sum of 2 quarters · filed 2013-01-29 | $33.81K derived: sum of 3 quarters · filed 2013-01-29 | $41.51K 10-K · filed 2013-01-29 |
| 2011-07-31 | $6.93K 10-Q · filed 2012-09-19 | $33.58K derived: sum of 2 quarters · filed 2012-09-19 | $41.28K 10-Q · filed 2012-09-19 | $42.39K derived: sum of 4 quarters · filed 2012-09-19 |
| 2011-04-30 | $26.65K 10-Q · filed 2012-06-14 | $34.35K 10-Q · filed 2012-06-14 | $35.46K derived: sum of 3 quarters · filed 2012-06-14 | $39.09K derived: sum of 4 quarters · filed 2012-06-14 |
| 2011-01-31 | $7.71K 10-Q · filed 2012-03-16 | $8.81K derived: sum of 2 quarters · filed 2012-03-16 | $12.44K derived: sum of 3 quarters · filed 2012-03-16 | |
| 2010-10-31 | $1.11K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $4.74K derived: sum of 2 quarters · filed 2012-01-30 | $16.11K 10-K · filed 2012-01-30 | |
| 2010-07-31 | $3.63K 10-Q/A · filed 2011-10-14 | $15.00K 10-Q/A · filed 2011-10-14 |